Eyam’s Chief Scientific Officer, Dr. Wilfred Jefferies, Inducted in the National Academy of Inventors
June 15, 2022
By Ryan M. Thomas
Today, Eyam Vaccines and Immunotherapeutics is pleased to announce that Dr. Wilfred Jefferies, Eyam’s Chief Scientific Officer, has been inducted as Fellow of the National Academy of Inventors.
Only the most accomplished inventors in academia are invited to join the National Academy of Inventors.
Dr. Jefferies was recognized for his many research discoveries and inventions in the field of biomedical research. The National Academy of Inventors induction ceremony took place today in Phoenix, Arizona.
The National Academy of Inventors is a non-profit organization with the mission to recognize and encourage academic invention. The NAI Fellows Program highlights academic inventors who have created or facilitated outstanding inventions that have made a positive impact on society.
As Eyam’s founder and Chief Scientific Officer, Dr. Jefferies is currently advancing several next generation vaccine technologies focused on COVID-19, influenza, and cancer.
Eyam’s Chief Scientific Officer, Dr. Wilfred Jefferies, Inducted in the National Academy of Inventors
June 15, 2022
By Ryan M. Thomas
Today, Eyam Vaccines and Immunotherapeutics is pleased to announce that Dr. Wilfred Jefferies, Eyam’s Chief Scientific Officer, has been inducted as Fellow of the National Academy of Inventors.
Only the most accomplished inventors in academia are invited to join the National Academy of Inventors.
Dr. Jefferies was recognized for his many research discoveries and inventions in the field of biomedical research. The National Academy of Inventors induction ceremony took place today in Phoenix, Arizona.
The National Academy of Inventors is a non-profit organization with the mission to recognize and encourage academic invention. The NAI Fellows Program highlights academic inventors who have created or facilitated outstanding inventions that have made a positive impact on society.
As Eyam’s founder and Chief Scientific Officer, Dr. Jefferies is currently advancing several next generation vaccine technologies focused on COVID-19, influenza, and cancer.
While uncertainty abounds, here at Eyam, we continue to make significant progress on our milestones, validate our new technologies, and prepare our vaccines for clinical trials.
